Related Experiment Video
Updated: Dec 6, 2025

12:29
Magnetic Resonance Imaging Quantification of Pulmonary Perfusion using Calibrated Arterial Spin Labeling
Published on: May 30, 2011
14.0K
Optimization of pseudo-continuous arterial spin labeling for renal perfusion imaging
Rebeca Echeverria-Chasco1,2, Marta Vidorreta3, Verónica Aramendía-Vidaurreta1,2
1Department of Radiology, Clínica Universidad de Navarra, Pamplona, Spain.
Magnetic Resonance in Medicine
|October 5, 2020
Summary
Optimizing pseudo-continuous arterial spin labeling (PCASL) gradient parameters enhances renal perfusion measurements. This study identifies specific gradient settings for improved labeling efficiency and robustness in kidney blood flow assessments.
Area of Science:
- Medical Imaging
- Biophysics
- Nephrology
Background:
- Pseudo-continuous arterial spin labeling (PCASL) is a non-invasive MRI technique for measuring blood flow.
- Optimizing PCASL parameters is crucial for accurate renal perfusion assessment, especially in patients with chronic kidney disease (CKD).
- Understanding the impact of gradient parameters on labeling efficiency and robustness is key to improving PCASL performance.
Purpose of the Study:
- To evaluate the labeling efficiency of PCASL.
- To determine gradient parameters that enhance PCASL robustness for renal perfusion measurements.
- To assess renal blood flow (RBF) in healthy controls and CKD patients using an optimized PCASL method.
Main Methods:
- Characterized aortic blood flow in young healthy volunteers, CKD patients, and healthy controls.
- Performed numeric simulations to evaluate PCASL inversion efficiency across various gradient parameters, considering pulsatile flow and off-resonance effects.
- Assessed PCASL implementation in vivo and measured RBF in CKD patients and healthy controls.
Main Results:
- Aortic blood velocities varied significantly between age groups and patient cohorts.
- Reduced gradient average (Gave) and selective to average gradient ratio (Gmax/Gave) maximized labeling efficiency and improved PCASL robustness.
- Significant differences in RBF were observed between CKD patients and healthy controls.
Conclusions:
- An optimal PCASL scheme for renal applications requires a Gmax/Gave ratio of 6-7.
- The Gave value should be adjusted based on aortic blood flow velocities (e.g., 0.5 mT/m for CKD patients and controls).
- This optimized PCASL approach enables robust renal perfusion measurements and reveals differences in RBF between patient groups.

